Jim Simons's position in Vertex Pharmaceuticals is currently worth $534 Million. That's 0.57% of their equity portfolio (23rd largest holding). The first Vertex Pharmaceuticals trade was made in Q3 2013. Since then Jim Simons bought shares seventeen more times and sold shares on fourteen occasions. The stake costed the investor $296 Million, netting the investor a gain of 80% so far.